These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1317477

  • 1. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease.
    Watson ML, Macnicol AM, Allan PL, Wright AF.
    Kidney Int; 1992 Jan; 41(1):206-10. PubMed ID: 1317477
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin blockade in late autosomal dominant polycystic kidney disease.
    Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RD, HALT-PKD Trial Investigators.
    N Engl J Med; 2014 Dec 11; 371(24):2267-76. PubMed ID: 25399731
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of lisinopril monotherapy on renal hemodynamics.
    Reams GP, Bauer JH.
    Am J Kidney Dis; 1988 Jun 11; 11(6):499-507. PubMed ID: 2837083
    [Abstract] [Full Text] [Related]

  • 5. Blood pressure in early autosomal dominant polycystic kidney disease.
    Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB, HALT-PKD Trial Investigators.
    N Engl J Med; 2014 Dec 11; 371(24):2255-66. PubMed ID: 25399733
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
    August P, Cody RJ, Sealey JE, Laragh JH.
    Am J Hypertens; 1989 Aug 11; 2(8):599-603. PubMed ID: 2550029
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension.
    Reams GP, Lau A, Knaus V, Bauer JH.
    J Clin Pharmacol; 1993 Apr 11; 33(4):348-53. PubMed ID: 8473550
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM, Al-Nimri MA, Oyama TT, Thompson MM, Kelly FJ, Chapman JG, Anderson S.
    Kidney Int; 1999 Dec 11; 56(6):2181-90. PubMed ID: 10594794
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vasoactive hormones in the renal response to systemic sepsis.
    Cumming AD, Driedger AA, McDonald JW, Lindsay RM, Solez K, Linton AL.
    Am J Kidney Dis; 1988 Jan 11; 11(1):23-32. PubMed ID: 3276170
    [Abstract] [Full Text] [Related]

  • 18. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R.
    Kidney Int; 2001 Jun 11; 59(6):2282-9. PubMed ID: 11380832
    [Abstract] [Full Text] [Related]

  • 19. ACE inhibitors, left ventricular mass and renal cyst growth in ADPKD.
    Schrier RW.
    Pharmacol Res; 2016 Dec 11; 114():166-168. PubMed ID: 27794499
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.